Sebi-Circular (89)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICCL advises BSE members of SEBI circular HO/47/17/12(11)2025-MRD-POD3/I/11107/2026 dated May 08, 2026, establishing norms for sharing and … | |||||||||||||||
ICCL advises BSE members of SEBI circular HO/47/17/12(11)2025-MRD-POD3/I/11107/2026 dated May 08, 2026, establishing norms for sharing and usage of price data for educational purposes.
| |||||||||||||||
BSE announces revocation of trading suspension for BMB Music & Magnetics Ltd equity shares effective May 21, 2026, with trading to resume in … | |||||||||||||||
BSE announces revocation of trading suspension for BMB Music & Magnetics Ltd equity shares effective May 21, 2026, with trading to resume in the 'XT' group pursuant to SEBI Master Circular dated January 30, 2026.
| |||||||||||||||
BSE notifies members of SEBI's decision to discontinue the Investor Risk Reduction Access (IRRA) platform, as per SEBI circular dated May … | |||||||||||||||
BSE notifies members of SEBI's decision to discontinue the Investor Risk Reduction Access (IRRA) platform, as per SEBI circular dated May 07, 2026.
| |||||||||||||||
SEBI has decided to discontinue the IRRA platform with immediate effect, citing structural redundancy due to robust alternative measures … | |||||||||||||||
SEBI has decided to discontinue the IRRA platform with immediate effect, citing structural redundancy due to robust alternative measures including BCP-DR requirements, Cyber Security frameworks, and Contingency Pool Trading facility.
| |||||||||||||||
SEBI revises the time lag for sharing and usage of market price data for educational purposes to 30 days, while granting NISM special access … | |||||||||||||||
SEBI revises the time lag for sharing and usage of market price data for educational purposes to 30 days, while granting NISM special access with a one-day lag for its simulation lab.
| |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 … | |||||||||||||||
BSE announces the opening of a tender offer buyback window for Jagsonpal Pharmaceuticals Limited, offering to repurchase up to 16,00,000 equity shares at Rs.250 per share for an aggregate consideration not exceeding Rs.40 crores.
| |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, directing all Regulated Entities to take note and … | |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, directing all Regulated Entities to take note and ensure compliance.
| |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, requiring all Regulated Entities to take note and … | |||||||||||||||
BSE forwards SEBI circular on emerging advanced AI tools for vulnerability detection, requiring all Regulated Entities to take note and ensure necessary compliance.
| |||||||||||||||
BSE forwards SEBI Circular No. HO/13/19/12(1)2026-ITD-1_CIMGI/10873/2026 dated May 05, 2026, advising all Regulated Entities on the use of … | |||||||||||||||
BSE forwards SEBI Circular No. HO/13/19/12(1)2026-ITD-1_CIMGI/10873/2026 dated May 05, 2026, advising all Regulated Entities on the use of emerging advanced Artificial Intelligence tools for cybersecurity vulnerability detection.
| |||||||||||||||
NSE forwards SEBI circular advising all trading members on the use of emerging advanced Artificial Intelligence (AI) tools for vulnerability … | |||||||||||||||
NSE forwards SEBI circular advising all trading members on the use of emerging advanced Artificial Intelligence (AI) tools for vulnerability detection in IT systems and cybersecurity frameworks.
| |||||||||||||||